erlotinib hydrochloride has been researched along with Extramembranous Glomerulopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Gu, X; Liu, X; Zhao, L; Zhou, X | 1 |
1 other study(ies) available for erlotinib hydrochloride and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Complete remission of membranous nephropathy in a patient with lung adenocarcinoma treated with erlotinib.
Topics: Adenocarcinoma of Lung; Erlotinib Hydrochloride; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Protein Kinase Inhibitors; Remission Induction; Treatment Outcome | 2020 |